BioLineRx Ltd. SEC filings BLRX
BioLineRx Ltd. has 617 filings in SEC EDGAR's recent list, going back to Sep 24, 2010. Its latest annual report, Form 20-F, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 23, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 2, 2026 | — |
| D | Filing | Sep 9, 2026 | — |
| EFFECT | Filing | Jan 5, 2024 | — |
| CT ORDER | Filing | Sep 21, 2021 | — |
| EFFECT | Filing | Feb 24, 2021 | — |
| EFFECT | Filing | Jan 11, 2021 | — |
| CORRESP | Letter to the SEC | Jan 11, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2021 | — |
| EFFECT | Filing | Aug 12, 2020 | — |
| EFFECT | Filing | Jul 2, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2020 | — |
| CORRESP | Letter to the SEC | Jul 1, 2020 | — |
| D | Filing | Jun 10, 2020 | — |
| D | Filing | Jun 10, 2020 | — |
| CT ORDER | Filing | Mar 23, 2020 | — |
| CT ORDER | Filing | Feb 19, 2020 | — |
| CT ORDER | Filing | Dec 13, 2019 | — |
| CT ORDER | Filing | May 20, 2019 | — |
| CT ORDER | Filing | Mar 21, 2019 | — |
| EFFECT | Filing | Feb 13, 2019 | — |
| CORRESP | Letter to the SEC | Feb 11, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2019 | — |
| CT ORDER | Filing | Oct 18, 2018 | — |
| CT ORDER | Filing | Apr 2, 2018 | — |
| EFFECT | Filing | Jan 19, 2018 | — |
| CORRESP | Letter to the SEC | Jan 18, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2018 | — |
| CT ORDER | Filing | Dec 4, 2017 | — |
| CT ORDER | Filing | Jun 22, 2017 | — |
| CT ORDER | Filing | Apr 10, 2017 | — |
| CT ORDER | Filing | Apr 7, 2017 | — |
| CT ORDER | Filing | Jul 18, 2016 | — |
| EFFECT | Filing | Oct 16, 2015 | — |
| CORRESP | Letter to the SEC | Oct 16, 2015 | — |
| CT ORDER | Filing | Sep 29, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2015 | — |
| CT ORDER | Filing | Aug 26, 2014 | — |
| EFFECT | Filing | Jun 12, 2014 | — |
| CT ORDER | Filing | May 16, 2014 | — |
| EFFECT | Filing | Aug 8, 2013 | — |
| CT ORDER | Filing | Mar 1, 2013 | — |
| EFFECT | Filing | Oct 12, 2012 | — |
| EFFECT | Filing | Aug 14, 2012 | — |
| EFFECT | Filing | Aug 1, 2012 | — |
| AW | Filing | Jul 25, 2012 | — |
| EFFECT | Filing | Mar 27, 2012 | — |
| EFFECT | Filing | Jul 21, 2011 | — |
| CT ORDER | Filing | Jul 21, 2011 | — |
| CERTNAS | Auto-generated paper document | Jul 21, 2011 | — |
| 20FR12B/A | Filing | Jul 15, 2011 | — |
| 20FR12B | Filing | Jul 1, 2011 | — |
| RW | Filing | Jul 1, 2011 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BLRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Modi-In
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1498403
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.